PRM58 - IMPACT OF FUTURE COSTS IN COST-EFFECTIVENESS ANALYSES AND A COMPARISON OF DIRECT AND INDIRECT METHODS USING MODELS OF CABAZITAXEL IN PROSTATE CANCER AND CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Abstract
Authors
J Tavi P Carita G Bégo-Le Bagousse F Joulain